We are live on ! Find out more
AHPI

Allied Healthcare Products

Delisted

AHPI was delisted on the 2nd of February, 2023.

1 hedge funds and large institutions have $0 invested in Allied Healthcare Products in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

92% less funds holding

Funds holding: 121 (-11)

100% less capital invested

Capital invested by funds: $114K → $0 (-$114K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 11

Holders
1
Holders Change
-11
Holders Change %
-91.67%
% of All Funds
0.02%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
1
Reduced
Closed
11
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
-$39K -42,600 Closed
Vanguard Group
2
Vanguard Group
Pennsylvania
-$26.6K -28,946 Closed
Geode Capital Management
3
Geode Capital Management
Massachusetts
-$20K -22,327 Closed
Dimensional Fund Advisors
4
Dimensional Fund Advisors
Texas
-$19 -20,622 Closed
SSA
5
Schonfeld Strategic Advisors
New York
-$15.9K -17,300 Closed
UBS Group
6
UBS Group
Switzerland
-$6.87K -7,466 Closed
USCWA
7
U.S. Capital Wealth Advisors
Texas
-$465 -500 Closed
Wells Fargo
8
Wells Fargo
California
-$21 -23 Closed
TRCT
9
Tower Research Capital (TRC)
New York
+$6.38K +6,816 +121%

AHPI Hedge Fund Activity: Q1 2023 in Review

1 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Allied Healthcare Products (AHPI) for Q1 2023, worth a combined $0 — down 100% from $114K a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of AHPI and 0 opened new positions — a net loss of 11 holders — while 0 trimmed existing stakes and 1 added.

The largest buyer was Tower Research Capital (TRC), adding an estimated $6.38K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $39K sold.

  • 1 institutional investor held Allied Healthcare Products (AHPI) as of Q1 2023, down from 12 in Q4 2022.
  • Funds reported $0 of Allied Healthcare Products stock for Q1 2023, down 100% quarter-over-quarter.
  • 0 funds opened new Allied Healthcare Products positions in Q1 2023 and 11 closed out, a net change of -11 holders.
  • The largest Allied Healthcare Products buyer in Q1 2023 was Tower Research Capital (TRC), an estimated $6.38K added.
  • The largest Allied Healthcare Products seller in Q1 2023 was Renaissance Technologies, an estimated $39K sold.

Based on aggregated 13F filings for Q1 2023.